Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Mangoceuticals, Inc. (MGRX) had Free Cash Flow per Share of $-0.08 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.07M |
|
$-3.40M |
|
$0.04M |
|
$0.03M |
|
$3.19M |
|
$-3.13M |
|
$-0.28M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-3.13M |
|
$-2.83M |
|
16.48M |
|
16.48M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$0.21M |
|
$0.00M |
|
$14.24M |
|
$14.45M |
|
$0.74M |
|
-- |
|
$0.24M |
|
$0.97M |
|
$13.47M |
|
$-0.47M |
|
$13.47M |
|
16.97M |
|
| Cash Flow Statement Financials | |
$-1.31M |
|
-- |
|
-- |
|
$1.49M |
|
$0.17M |
|
$-1.31M |
|
$0.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
42.73% |
|
-4606.75% |
|
-4606.75% |
|
-- |
|
-5014.65% |
|
-5014.66% |
|
$-1.31M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-25.26% |
|
729.51% |
|
-23.55% |
|
-25.26% |
|
$0.79 |
|
|
Free Cash Flow per Share |
$-0.08 |
$-0.08 |
|